Literature DB >> 20065884

The impact of smoking on antimüllerian hormone levels in women aged 38 to 50 years.

Beth J Plante1, Glinda S Cooper, Donna D Baird, Anne Z Steiner.   

Abstract

OBJECTIVE: Smoking is associated with increased follicle-stimulating hormone levels and early menopause. Smoking may directly accelerate ovarian follicular depletion or may act indirectly by increasing the pituitary production of follicle-stimulating hormone. Antimüllerian hormone (AMH), produced by ovarian follicles, is a more direct measure of ovarian reserve. The objective of our study was to determine the extent to which smoking influences ovarian reserve, as measured by AMH levels.
METHODS: A community sample of 284 women aged 38 to 50 years completed a self-administered questionnaire including a detailed smoking history. Serum AMH levels were measured on day 2, 3, or 4 of the menstrual cycle. The association between AMH and smoking was analyzed using linear regression, adjusting for age and body mass index.
RESULTS: Participants aged 38 to 42, 43 to 45, and 46 to 50 years had geometric mean AMH values of 6.7 pM (95% CI, 5.2-8.7 pM), 2.7 pM (95% CI, 1.9-3.8 pM), and 1.3 pM (95% CI, 1.0-1.7 pM), respectively. Current smokers, but not past smokers, had 44% lower AMH values than did the reference group (participants with neither active nor former or passive smoke exposure; P = 0.04). Passive smoking had no effect on AMH values when compared with the reference group (P = 0.55). The impact of smoking on AMH values was not dose dependent based on cigarettes per day (P = 0.08) or pack-years (P = 0.22). Finally, prenatal exposure to smoking (either maternal or paternal) had no impact on AMH levels (P = 0.47 and P = 0.89, respectively).
CONCLUSIONS: Active smoking, but not former smoking, is associated with decreased AMH values in late-reproductive-age and perimenopausal women, suggesting a possible direct effect of smoking on the depletion of the antral but not primordial follicles. The direct impact of active smoking on AMH levels in younger women requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065884      PMCID: PMC2866786          DOI: 10.1097/gme.0b013e3181c7deba

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  40 in total

1.  Active and passive smoking and the occurrence of natural menopause.

Authors:  G S Cooper; D P Sandler; M Bohlig
Journal:  Epidemiology       Date:  1999-11       Impact factor: 4.822

2.  Earlier age at menopause, work, and tobacco smoke exposure.

Authors:  Lora E Fleming; Silvina Levis; William G LeBlanc; Noella A Dietz; Kristopher L Arheart; James D Wilkinson; John Clark; Berrin Serdar; Evelyn P Davila; David J Lee
Journal:  Menopause       Date:  2008 Nov-Dec       Impact factor: 2.953

3.  Antimüllerian hormone serum levels: a putative marker for ovarian aging.

Authors:  Annemarie de Vet; Joop S E Laven; Frank H de Jong; Axel P N Themmen; Bart C J M Fauser
Journal:  Fertil Steril       Date:  2002-02       Impact factor: 7.329

4.  Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals.

Authors:  T Matikainen; G I Perez; A Jurisicova; J K Pru; J J Schlezinger; H Y Ryu; J Laine; T Sakai; S J Korsmeyer; R F Casper; D H Sherr; J L Tilly
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

5.  A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.

Authors:  Kannamannadiar Jayaprakasan; Bruce Campbell; James Hopkisson; Ian Johnson; Nick Raine-Fenning
Journal:  Fertil Steril       Date:  2008-11-30       Impact factor: 7.329

6.  Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids.

Authors:  Isabelle Streuli; Timothée Fraisse; Christine Pillet; Victoria Ibecheole; Paul Bischof; Dominique de Ziegler
Journal:  Fertil Steril       Date:  2007-10-24       Impact factor: 7.329

7.  A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause.

Authors:  Fahimeh Ramezani Tehrani; Masoud Solaymani-Dodaran; Fereidoun Azizi
Journal:  Menopause       Date:  2009 Jul-Aug       Impact factor: 2.953

8.  Variations in serum müllerian inhibiting substance between white, black, and Hispanic women.

Authors:  David B Seifer; Elizabeth T Golub; Geralyn Lambert-Messerlian; Lorie Benning; Kathryn Anastos; D Heather Watts; Mardge H Cohen; Roksana Karim; Mary A Young; Howard Minkoff; Ruth M Greenblatt
Journal:  Fertil Steril       Date:  2008-10-18       Impact factor: 7.329

Review 9.  Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance.

Authors:  David B Seifer; David T Maclaughlin
Journal:  Fertil Steril       Date:  2007-06-07       Impact factor: 7.329

10.  Early menopause, association with tobacco smoking, coffee consumption and other lifestyle factors: a cross-sectional study.

Authors:  Thea F Mikkelsen; Sidsel Graff-Iversen; Johanne Sundby; Espen Bjertness
Journal:  BMC Public Health       Date:  2007-07-07       Impact factor: 3.295

View more
  44 in total

1.  Anti-Müllerian hormone: a potential new tool in epidemiologic studies of female fecundability.

Authors:  Donna D Baird; Anne Z Steiner
Journal:  Am J Epidemiol       Date:  2012-01-12       Impact factor: 4.897

2.  Prospective study of cigarette smoking and fecundability.

Authors:  Amelia K Wesselink; Elizabeth E Hatch; Kenneth J Rothman; Ellen M Mikkelsen; Ann Aschengrau; Lauren A Wise
Journal:  Hum Reprod       Date:  2019-03-01       Impact factor: 6.918

Review 3.  Dynamics of the ovarian reserve and impact of genetic and epidemiological factors on age of menopause.

Authors:  Emanuele Pelosi; Eleanor Simonsick; Antonino Forabosco; Jose Elias Garcia-Ortiz; David Schlessinger
Journal:  Biol Reprod       Date:  2015-04-22       Impact factor: 4.285

4.  Innovations in translational sex and gender-sensitive tobacco research.

Authors:  Sherry A McKee; Andrea H Weinberger
Journal:  Nicotine Tob Res       Date:  2015-03-11       Impact factor: 4.244

5.  Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women.

Authors:  Ellen W Freeman; Mary D Sammel; Hui Lin; Clarisa R Gracia
Journal:  J Clin Endocrinol Metab       Date:  2012-02-29       Impact factor: 5.958

6.  Antimüllerian hormone in relation to tobacco and marijuana use and sources of indoor heating/cooking.

Authors:  Alexandra J White; Dale P Sandler; Aimee A D'Aloisio; Frank Stanczyk; Kristina W Whitworth; Donna D Baird; Hazel B Nichols
Journal:  Fertil Steril       Date:  2016-05-27       Impact factor: 7.329

7.  Serum antimüllerian hormone in healthy premenopausal women.

Authors:  Christiana M Shaw; Frank Z Stanczyk; Brian L Egleston; L L Kahle; Cynthia S Spittle; Andrew K Godwin; Louise A Brinton; Joanne F Dorgan
Journal:  Fertil Steril       Date:  2011-06-30       Impact factor: 7.329

8.  Association between serum 25-hydroxyvitamin D and ovarian reserve in premenopausal women.

Authors:  Anne Marie Z Jukic; Anne Z Steiner; Donna D Baird
Journal:  Menopause       Date:  2015-03       Impact factor: 2.953

Review 9.  Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation.

Authors:  Andrea H Weinberger; Philip H Smith; Sharon S Allen; Kelly P Cosgrove; Michael E Saladin; Kevin M Gray; Carolyn M Mazure; Cora Lee Wetherington; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

10.  Impact of breast cancer on anti-mullerian hormone levels in young women.

Authors:  H I Su; S W Flatt; L Natarajan; A DeMichele; A Z Steiner
Journal:  Breast Cancer Res Treat       Date:  2012-12-09       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.